Takeda Pharmaceutical TAK Peer Comparison

NYSE TAK
$18.26 -0.06 (-0.30%)
As of: Sep 9, 2026 · 12:05 PM EDT
Peer Comparison

300 Comparable Companies

Industry Pharmaceuticals

Takeda Pharmaceutical Co Ltd (TAK) is the 112th largest of 300 Pharmaceuticals companies by market capitalisation, at 2.62 Bn, behind Mineralys Therapeutics, Inc. at 2.62 Bn. It trades on a P/E of 4.56, 76% below the peer median of 18.83. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 JNJ Johnson & Johnson primary H-01 Pharmaceuticals and Biotechnology HG-01 647.54 Bn 30.78 6.61 626.78 Bn
2 ABBV AbbVie Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 441.45 Bn 69.89 6.86 434.88 Bn
3 MRK Merck & Co., Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 364.78 Bn 115.11 5.48 357.64 Bn
4 NVS Novartis Ag primary H-01 Pharmaceuticals and Biotechnology HG-01 267.01 Bn 9.27 3.89 259.32 Bn
5 PFE Pfizer Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 158.95 Bn 36.39 2.50 147.25 Bn
6 SNY Sanofi primary H-01 Pharmaceuticals and Biotechnology HG-01 52.54 Bn 11.27 0.98 45.16 Bn
7 RVMD Revolution Medicines, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 44.23 Bn -25.01 — 44.23 Bn
8 INCY Incyte Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 25.36 Bn 15.73 4.36 20.82 Bn
9 UTHR UNITED THERAPEUTICS Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 21.31 Bn 16.26 6.76 18.65 Bn
10 NBIX Neurocrine Biosciences Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.53 Bn 22.02 4.60 15.15 Bn
11 JAZZ Jazz Pharmaceuticals plc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.13 Bn 16.08 3.29 13.51 Bn
12 EXEL Exelixis, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 14.41 Bn 16.75 5.92 13.57 Bn
13 CORT Corcept Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 12.29 Bn 226.82 14.80 11.99 Bn
14 KYMR Kymera Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 11.40 Bn -38.04 108.54 10.71 Bn
15 AXSM Axsome Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 10.88 Bn -70.79 14.01 10.56 Bn
16 NUVL Nuvalent, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 9.75 Bn -27.07 — 9.75 Bn
17 CYTK Cytokinetics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 9.74 Bn -13.28 143.91 8.57 Bn
18 GPCR Structure Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 9.41 Bn -50.01 — 9.41 Bn
19 CRNX Crinetics Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 8.99 Bn -17.90 213.22 8.99 Bn
20 ALKS Alkermes plc. primary H-01 Pharmaceuticals and Biotechnology HG-01 7.59 Bn 114.81 4.55 6.94 Bn
21 BLTE Belite Bio, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 6.21 Bn 0.08 — 6.21 Bn
22 TVTX Travere Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 6.18 Bn -142.29 10.46 6.07 Bn
23 LQDA Liquidia Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 6.09 Bn 43.92 13.50 5.80 Bn
24 AMRN Amarin Corp Plc\Uk primary H-01 Pharmaceuticals and Biotechnology HG-01 5.96 Bn -219.55 31.98 5.64 Bn
25 ACAD Acadia Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.78 Bn 12.55 4.19 3.82 Bn
26 EWTX Edgewise Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.66 Bn -23.64 — 4.66 Bn
27 DFTX Definium Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.20 Bn -11.88 — 4.20 Bn
28 INDV Indivior Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.05 Bn 11.41 3.04 3.83 Bn
29 MANE Veradermics, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.01 Bn -46.57 — 4.01 Bn
30 CPRX CATALYST PHARMACEUTICALS, INC. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn 17.94 6.45 3.09 Bn
31 ELVN Enliven Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn -45.72 — 3.85 Bn
32 TARS Tarsus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.66 Bn -78.05 6.04 3.21 Bn
33 OGN Organon & Co. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.61 Bn 17.26 0.59 2.47 Bn
34 NAMS NewAmsterdam Pharma Co N.V. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.90 Bn -11.17 407.13 2.90 Bn
35 MLYS Mineralys Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.62 Bn -7.51 — 2.62 Bn
36 TAK Takeda Pharmaceutical Co Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 2.62 Bn 4.56 0.06 -3.18 Bn
37 TRVI Trevi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.61 Bn -61.82 — 2.61 Bn
38 BEIGF BeOne Medicines Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
39 SUPN Supernus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -28.61 3.09 2.06 Bn
40 HRMY Harmony Biosciences Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.43 Bn 13.64 2.53 1.63 Bn
41 NUVB Nuvation Bio Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -21.22 13.51 2.29 Bn
42 PVLA Palvella Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.19 Bn -41.35 — 1.88 Bn
43 AUPH Aurinia Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 6.67 6.73 1.65 Bn
44 ETON Eton Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.64 Bn 171.80 16.36 1.61 Bn
45 INVA Innoviva, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.54 Bn 7.84 2.99 0.96 Bn
46 LBRX Lb Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -24.09 — 1.46 Bn
47 XERS Xeris Biopharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -84.47 4.32 1.33 Bn
48 HROW Harrow, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -42.26 5.13 1.33 Bn
49 OPK Opko Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.19 Bn -31.29 2.02 0.88 Bn
50 OLMA Olema Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.11 Bn -5.42 — 1.11 Bn
51 KURA Kura Oncology, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.08 Bn -4.53 13.97 1.08 Bn
52 PCRX Pacira BioSciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 69.00 1.35 0.76 Bn
53 LXRX Lexicon Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -15.13 22.94 0.76 Bn
54 DSGN Design Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -11.76 — 0.74 Bn
55 SGP SpyGlass Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.93 Bn -48.72 — 0.93 Bn
56 VSTM Verastem, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -6.99 9.20 0.67 Bn
57 COLL Collegium Pharmaceutical, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.77 Bn 16.02 0.95 0.62 Bn
58 PHAT Phathom Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -7.56 3.10 0.56 Bn
59 ZVRA Zevra Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 12.55 5.37 0.51 Bn
60 GYRE Gyre Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.71 Bn -38.37 5.93 0.65 Bn
61 IVEVF Inventiva S.A. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 7.19 132.94 0.69 Bn
62 CRMD CorMedix Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 5.09 1.71 0.38 Bn
63 AQST Aquestive Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -8.18 11.83 0.54 Bn
64 MPLT MapLight Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.62 Bn -3.07 — 0.62 Bn
65 EOLS Evolus, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -16.63 1.80 0.53 Bn
66 NVCT Nuvectis Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -18.13 — 0.55 Bn
67 OVID Ovid Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.53 Bn -15.46 336.78 0.42 Bn
68 SPRY ARS Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -2.37 4.48 0.38 Bn
69 PALI Palisade Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -12.61 889.92 0.32 Bn
70 XFOR X4 Pharmaceuticals, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.91 27.94 0.25 Bn
71 IKT Inhibikase Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -6.46 — 0.26 Bn
72 TTRX Turn Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -53.83 — 0.41 Bn
73 VTVT vTv Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -85.61 11.05 0.41 Bn
74 SION Sionna Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -3.42 — 0.33 Bn
75 ACHV Achieve Life Sciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.33 Bn — — 0.33 Bn
76 VNDA Vanda Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.15 1.46 0.15 Bn
77 IMRX Immuneering Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -5.12 — 0.30 Bn
78 EBS Emergent BioSolutions Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -1.66 0.38 0.15 Bn
79 FULC Fulcrum Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -3.25 — 0.29 Bn
80 ZNTL Zentalis Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.97 — 0.28 Bn
81 AKBA Akebia Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.88 1.20 0.11 Bn
82 CELG-RI Bristol Myers Squibb Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.02 0.00 -10.84 Bn
83 SIGA Siga Technologies Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn — — 0.07 Bn
84 TNXP Tonix Pharmaceuticals Holding Corp. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.35 7.42 0.22 Bn
85 DERM Journey Medical Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -57.60 3.09 0.18 Bn
86 CRDL Cardiol Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -7.78 — 0.20 Bn
87 ACOG Alpha Cognition Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -7.30 14.98 0.16 Bn
88 NERV Minerva Neurosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -30.08 — 0.20 Bn
89 SLGL Sol-Gel Technologies Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -18.47 107.94 0.15 Bn
90 MCUJF Medicure Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -37.45 8.18 0.19 Bn
91 LONA LeonaBio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.52 — 0.13 Bn
92 MENS Jyong Biotech Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -46.69 — 0.16 Bn
93 LENZ LENZ Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -1.24 7.47 0.16 Bn
94 BMEA Biomea Fusion, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.37 — 0.13 Bn
95 VANI Vivani Medical, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -4.27 — 0.10 Bn
96 VRCA Verrica Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.44 3.57 0.10 Bn
97 AARD Aardvark Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -1.54 — 0.03 Bn
98 CPIX Cumberland Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -8.98 3.10 0.09 Bn
99 TENX Tenax Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -1.48 — 0.10 Bn
100 CGTX Cognition Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.50 — 0.09 Bn
101 NTHI Neonc Technologies Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.04 — 0.09 Bn
102 MNOV Medicinova Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -7.59 99.85 0.09 Bn
103 PTHS Pelthos Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -0.76 1.57 0.06 Bn
104 RGC Regencell Bioscience Holdings Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn — — 0.08 Bn
105 PMVP PMV Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.21 — -0.01 Bn
106 PLRX Pliant Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -0.77 — 0.07 Bn
107 BOLD Boundless Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.00 — 0.06 Bn
108 VERU Veru Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 117.37 — 0.03 Bn
109 GOSS Gossamer Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.30 0.96 -0.01 Bn
110 KPTI Karyopharm Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.25 0.33 -0.02 Bn
111 ANVS Annovis Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.96 — 0.05 Bn
112 CLNN Clene Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.34 213.14 0.04 Bn
113 APRE Aprea Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.42 — 0.04 Bn
114 IXHL Incannex Healthcare Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.85 — 0.04 Bn
115 SCLX Scilex Holding Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.08 1.18 -0.08 Bn
116 GRCE Grace Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.85 — 0.04 Bn
117 CPHI China Pharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -7.57 8.66 0.03 Bn
118 UG United Guardian Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 14.56 2.94 0.02 Bn
119 ACTU Actuate Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.54 — 0.03 Bn
120 NSRX Nasus Pharma Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -5.64 — 0.03 Bn
121 BYSI BeyondSpring Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.02 — 0.03 Bn
122 CRVO CervoMed Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.84 76.69 0.03 Bn
123 TXMD TherapeuticsMD, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -135.76 7.68 0.02 Bn
124 YARW Yarrow Bioscience, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.12 46.85 0.00 Bn
125 AYTU Aytu Biopharma, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.75 0.40 0.00 Bn
126 ATOS Atossa Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.72 — 0.02 Bn
127 ALLR Allarity Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.68 814.63 0.02 Bn
128 BFRI Biofrontera Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.31 0.45 0.02 Bn
129 MIRA Mira Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.56 — 0.01 Bn
130 TVRD Tvardi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.68 — 0.02 Bn
131 KPRX Kiora Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.42 — 0.02 Bn
132 CTXR Citius Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.34 2.18 0.02 Bn
133 ANEB Anebulo Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.64 — 0.01 Bn
134 INTI Inhibitor Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -3.67 — 0.01 Bn
135 CALC CalciMedica, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.32 -8.02 -0.01 Bn
136 RVPH Reviva Pharmaceuticals Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.74 — 0.01 Bn
137 CURX Curanex Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.88 — 0.00 Bn
138 ADXN Addex Therapeutics Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.05 — 0.01 Bn
139 ACXP Acurx Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.81 — 0.01 Bn
140 PULM Pulmatrix, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.46 — 0.01 Bn
141 TRAW Traws Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.34 — 0.00 Bn
142 PCSA Processa Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.41 — 0.01 Bn
143 TCRT Alaunos Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.94 1,276.64 0.00 Bn
144 BICX BioCorRx Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.64 6.70 0.00 Bn
145 CVKD Cadrenal Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.29 — 0.00 Bn
146 CASIF CASI Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 0.12 0.00 Bn
147 OGEN Oragenics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.23 — 0.00 Bn
148 UPC Universe Pharmaceuticals INC primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -1,490.23 Bn
149 CANF Can-Fite BioPharma Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.24 5.93 0.00 Bn
150 ENSC Ensysce Biosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
151 MTNB Matinas BioPharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.16 — 0.00 Bn
152 SKVI Skinvisible, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.05 54.04 0.00 Bn
153 SPRC SciSparc Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.05 0.76 0.00 Bn
154 NCEL NewcelX Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.06 — 0.00 Bn
155 GLMD Galmed Pharmaceuticals Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
156 CDT CDT Equity Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 — 0.00 Bn
157 JAGX Jaguar Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 0.01 -0.01 Bn
158 GCAN Trafalgar International, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.77 — 0.00 Bn
159 CINGW Cingulate Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — 0.00 Bn
160 SXTC China SXT Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.03 -0.03 Bn
161 CMND Clearmind Medicine Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — -0.01 Bn
162 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 211.88 Bn 24.23 5.56 197.89 Bn
163 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 181.55 Bn -62.71 5.96 178.37 Bn
164 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 132.31 Bn 30.03 10.51 124.45 Bn
165 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 82.51 Bn 19.06 5.31 74.52 Bn
166 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 61.54 Bn 35.88 11.78 56.36 Bn
167 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 54.69 Bn -17.36 24.55 49.55 Bn
168 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.93 Bn 61.68 2.48 39.28 Bn
169 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 34.07 Bn 43.98 7.09 30.76 Bn
170 ALC Alcon Inc secondary H-06 Medical Devices and Diagnostics HG-02 33.97 Bn 52.83 3.16 32.51 Bn
171 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 31.41 Bn 37.63 3.13 30.12 Bn
172 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 30.10 Bn -20.28 2,755.62 30.10 Bn
173 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 29.92 Bn 14.59 1.41 27.81 Bn
174 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.83 Bn -31.80 24.46 26.67 Bn
175 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 23.55 Bn -13.82 7.61 9.89 Bn
176 VTRS Viatris Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 19.25 Bn -46.86 1.31 18.36 Bn
177 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.18 Bn 21.46 2.14 17.77 Bn
178 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.96 Bn 18.40 11.26 15.01 Bn
179 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.83 Bn -49.63 12.33 14.99 Bn
180 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.67 Bn -21.20 20.57 13.95 Bn
181 BWXT BWX Technologies, Inc. secondary I-39 Clean Energy Equipment IG-10 14.48 Bn 40.67 4.12 13.88 Bn
182 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.50 Bn — — 12.81 Bn
183 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.59 Bn 30.45 7.57 12.36 Bn
184 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.52 Bn 171.54 3.67 11.64 Bn
185 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.10 Bn -44.46 18.07 10.50 Bn
186 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
187 GKOS GLAUKOS Corp secondary H-06 Medical Devices and Diagnostics HG-02 10.68 Bn -67.82 17.43 10.57 Bn
188 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.20 Bn -26.74 — 9.44 Bn
189 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
190 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.08 Bn 18.83 3.21 9.49 Bn
191 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.86 Bn 781.50 2.69 9.69 Bn
192 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.61 Bn 86.99 34.06 9.61 Bn
193 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.24 Bn -43.53 10.57 7.18 Bn
194 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.60 Bn -8.14 — 8.60 Bn
195 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.46 Bn -8.52 51.02 8.10 Bn
196 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.02 Bn -14.89 — 8.02 Bn
197 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.76 Bn 17.57 9.71 7.08 Bn
198 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
199 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.48 Bn -41.79 — 7.48 Bn
200 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.18 Bn -17.78 — 7.18 Bn
201 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.88 Bn -32.74 28.69 6.55 Bn
202 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.43 Bn -39.46 1.21 6.05 Bn
203 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.38 Bn -28.49 1,025.18 6.38 Bn
204 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.34 Bn -7.37 10.26 5.90 Bn
205 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.30 Bn -703.30 4,524.98 6.30 Bn
206 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.20 Bn 76.84 7.37 5.67 Bn
207 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.98 Bn -16.17 — 5.98 Bn
208 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.86 Bn — — 4.13 Bn
209 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.86 Bn -16.15 — 5.86 Bn
210 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -33.17 1,163.09 5.66 Bn
211 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.80 Bn 29.39 19.95 4.44 Bn
212 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.62 Bn 14.70 5.57 3.39 Bn
213 AMRX Amneal Pharmaceuticals, Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 5.52 Bn 25.65 1.77 5.39 Bn
214 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.04 Bn -17.55 — 5.04 Bn
215 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.03 Bn -22.99 — 5.03 Bn
216 FMCQF Fresenius Medical Care AG secondary H-14 Healthcare Providers HG-04 4.79 Bn 4.57 0.17 4.09 Bn
217 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.04 Bn — — 3.63 Bn
218 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -7.86 1,115.68 4.02 Bn
219 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
220 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.86 Bn -7.21 — 3.86 Bn
221 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.86 Bn -18.46 11.87 3.56 Bn
222 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.85 Bn -13.47 372.09 3.85 Bn
223 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.69 Bn -30.34 — 3.69 Bn
224 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.60 Bn -35.16 66.87 2.58 Bn
225 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.58 Bn -7.79 30.62 2.88 Bn
226 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.54 Bn -16.08 15.12 2.71 Bn
227 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.39 Bn -20.57 51.19 3.39 Bn
228 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.23 Bn -6.26 — 3.23 Bn
229 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.14 Bn 110.36 6.78 2.91 Bn
230 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.01 Bn -9.80 19,070.80 3.01 Bn
231 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -11.06 593.06 2.47 Bn
232 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -28.43 — 2.96 Bn
233 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn -14.62 — 2.94 Bn
234 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.92 Bn -8.55 79.36 2.47 Bn
235 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.83 Bn -15.03 6.29 2.12 Bn
236 CURLF Curaleaf Holdings, Inc. secondary S-09 Tobacco and Cannabis SG-04 2.72 Bn -22.95 2.08 2.63 Bn
237 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.63 Bn -81.01 — 2.63 Bn
238 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn -8.40 48.85 2.54 Bn
239 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.54 Bn -171.60 10.11 2.43 Bn
240 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.47 Bn -6.17 — 2.47 Bn
241 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn -20.61 44.88 1.77 Bn
242 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.42 Bn -6.05 34.03 2.42 Bn
243 BHC Bausch Health Companies Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2.18 0.22 0.55 Bn
244 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.35 Bn -17.11 1.19 1.55 Bn
245 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.33 Bn -37.44 12.35 2.22 Bn
246 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.31 Bn -5.99 4.31 1.95 Bn
247 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.25 Bn -3.84 — 1.99 Bn
248 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn -11.19 — 1.85 Bn
249 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 12.97 4.21 2.02 Bn
250 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.17 0.34 0.65 Bn
251 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn -2,975.41 — 2.15 Bn
252 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn -8.84 — 2.14 Bn
253 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.12 Bn -15.43 105.83 2.12 Bn
254 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.07 Bn -5.03 21.06 2.07 Bn
255 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.05 Bn -4.92 2,045.15 2.05 Bn
256 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.00 Bn -13.35 53.95 1.73 Bn
257 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.99 Bn -5.05 — 1.99 Bn
258 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn -9.43 71.00 1.67 Bn
259 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn -11.75 18.28 1.54 Bn
260 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn -14.36 1,473.61 1.92 Bn
261 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.81 Bn -7.20 5.97 1.81 Bn
262 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn -9.78 7.03 1.22 Bn
263 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.76 Bn -97.45 4.09 0.88 Bn
264 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn -124.42 17.57 1.74 Bn
265 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
266 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -3.31 31.35 1.17 Bn
267 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -6.27 — 1.11 Bn
268 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.64 Bn -26.30 — 1.28 Bn
269 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.61 Bn -8.70 — 1.61 Bn
270 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.61 Bn -6.49 3.88 0.89 Bn
271 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -66.91 8.02 1.31 Bn
272 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -10.35 524.82 1.59 Bn
273 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
274 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.56 Bn -186.21 905.74 1.56 Bn
275 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -9.11 20.12 1.26 Bn
276 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -18.03 — 1.51 Bn
277 ANIP Ani Pharmaceuticals Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 1.50 Bn 13.88 1.53 1.14 Bn
278 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -3.23 2.08 1.20 Bn
279 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -13.93 73.88 1.48 Bn
280 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -9.45 50.66 0.82 Bn
281 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.44 Bn -26.51 5.56 1.03 Bn
282 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -8.68 — 1.42 Bn
283 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -4.75 — 1.41 Bn
284 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.39 Bn -9.37 — 1.39 Bn
285 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 80.63 35.82 1.38 Bn
286 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -11.35 880.17 1.17 Bn
287 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -9.79 — 1.36 Bn
288 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn -8.55 — 1.34 Bn
289 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.32 Bn -6.47 — 1.32 Bn
290 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.29 Bn -5.34 155.27 0.79 Bn
291 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -1.39 — 1.28 Bn
292 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -12.05 51.49 1.24 Bn
293 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -27.97 3.10 1.11 Bn
294 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -25.48 — 1.00 Bn
295 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -7.71 — 1.18 Bn
296 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -20.47 — 1.18 Bn
297 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -4.72 23.40 0.68 Bn
298 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.04 Bn -3.92 — 0.50 Bn
299 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.59 0.92 Bn
300 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -4.85 15.01 0.61 Bn